2024-02-22 11:16:41
The Bayer laboratory alerted pharmacists on Wednesday February 21 of an anomaly in a box of its Euphytose product. A sleeping pill had slipped into the wrong box. The laboratory assures that the case is “isolated” and announces to BFMTV.com that it is carrying out an investigation.
A document stamped “urgent information” fell on the desks of all pharmacists on Wednesday February 21. In a note addressed to pharmacies that BFMTV.com was able to consult, the Bayer laboratory announced “in agreement with the ANSM” the recall of a batch of its popular product, Euphytose.
It is a herbal medicine available without a prescription and recommended for sleep disorders and anxiety, as Vidal explains.
16,000 boxes recalled
A box of this general public product “marketed throughout France” was compromised for reasons that remain to be established. The problem? One person found a “blue tablet” in his tube which was not Euphytose but “Phenergan 25mg”, a prescription medication prescribed as a sleeping pill.
“The precise origin of this event is currently under investigation,” the Bayer laboratory explains to BFMTV.com. For the moment, only one batch is affected following a report.
“Pharmacists are asked to take all measures within their pharmacy to inform patients of this recall,” specify the laboratory and the Medicines Safety Agency (ANSM) to French pharmacists. The recalled medications will subsequently be destroyed.
A defective box can be quickly identified: the herbal product seals are brown, the others are blue. The lot concerned is as follows: Lot SX2298 with expiry date 03/2025. Those concerned should contact their pharmacist or doctor.
An “isolated case”, ongoing investigations
How might such a mixture have taken place? The laboratory manufactures Euphytose and Phenergan in the same factory. They announced to BFMTV.com the opening of investigations to determine how the product might have ended up on another manufacturing line. The “isolated” nature of this event is underlined.
The recall of 16,000 boxes for a single problematic case is to avoid all risks. Due to the availability and popularity of this product among the general public, the Medicines Safety Agency is planning a communications campaign to alert consumers of this recall.
These product recalls on pharmacy shelves are “rather rare”, as explained by the Order of the Profession. Numerous checks are carried out upstream at all stages of the chain to avoid this type of incident.
1708605689
#boxes #recalled #discovery #drug #tube #investigation #opened
